Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BETR-001 shows antidepressant activity in preclinical models

April 7, 2022

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

April 7, 2022

Compass Pathfinder synthesizes new safrylamine derivatives

April 5, 2022

HCAR2 targeting modulates the progression of AD in mice

April 5, 2022

Molecular chaperone maintains proteostasis by clearing protein aggregates in cell

April 4, 2022

Discovery of alpha-syn aggregation inhibitors for the treatment of PD

April 4, 2022

LY-3372689, a novel OGA enzyme inhibitor for the treatment of Alzheimer's disease

April 4, 2022

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

March 31, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...